|
1
|
Vander Griend RA: Osteosarcoma and its
variants. Orthop Clin North Am. 27:575–581. 1996.PubMed/NCBI
|
|
2
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simpson S, Dunning MD, de Brot S,
Grau-Roma L, Mongan NP and Rutland CS: Comparative review of human
and canine osteosarcoma: Morphology, epidemiology, prognosis,
treatment and genetics. Acta Vet Scand. 59:712017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang S, Hui Y, Li X and Jia Q: Silencing
of lncRNA-CCDC26 restrains the growth and migration of glioma cells
in vitro and in vivo via targeting miR-203. Oncol Res: Jun 9, 2017
(Epub ahead of print).
|
|
6
|
Li J, Zi Y, Wang W and Li Y: Long
noncoding RNA MEG3 inhibits cell proliferation and metastasis in
chronic myeloid leukemia via targeting miR-184. Oncol Res.
26:297–305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu K, He Y, Xia C, Yan J, Hou J, Kong D,
Yang Y and Zheng G: MicroRNA-15a inhibits proliferation and induces
apoptosis in CNE1 nasopharyngeal carcinoma cells. Oncol Res.
24:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res: May 22, 2017 (Epub ahead of
print).
|
|
10
|
Yang M, Zhai X, Ge T, Yang C and Lou G:
MiR-181a-5p promotes proliferation and invasion and inhibits
apoptosis of cervical cancer cells via regulating inositol
polyphosphate-5-phosphatase A (INPP5A). Oncol Res: Jun 23, 2017
(Epub ahead of print).
|
|
11
|
Wang Y, Li J, Xu C and Zhang X:
MicroRNA-139-5p inhibit cell proliferation and invasion by
targeting RHO-associated coiled-coil containing protein kinase 2 in
ovarian cancer. Oncol Res: Jun 14, 2017 (Epub ahead of print).
|
|
12
|
Wang C, Zhou B, Liu M, Liu Y and Gao R:
miR-126-5p restoration promotes cell apoptosis in cervical cancer
by targeting Bcl2l2. Oncol Res. 25:463–470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Z, Guo J, Ma Y, Zhang L and Lin Z:
Oncogenic role of MicroRNA-30b-5p in glioblastoma through targeting
proline-rich transmembrane protein 2. Oncol Res. 26:219–230. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hua F, Li CH, Chen XG and Liu XP: Long
noncoding RNA CCAT2 knockdown suppresses tumorous progression by
sponging miR-424 in epithelial ovarian cancer. Oncol Res.
26:241–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu J, Shi H, Liu H, Wang X and Li F: Long
non-coding RNA TUG1 promotes cervical cancer progression by
regulating the miR-138-5p-SIRT1 axis. Oncotarget. 8:65253–65264.
2017.PubMed/NCBI
|
|
17
|
Yan G, Wang X, Yang M, Lu L and Zhou Q:
Long non-coding RNA TUG1 promotes progression of oral squamous cell
carcinoma through upregulating FMNL2 by sponging miR-219. Am J
Cancer Res. 7:1899–1912. 2017.PubMed/NCBI
|
|
18
|
Ma B, Li M, Zhang L, Huang M, Lei JB, Fu
GH, Liu CX, Lai QW, Chen QQ and Wang YL: Upregulation of long
non-coding RNA TUG1 correlates with poor prognosis and disease
status in osteosarcoma. Tumour Biol. 37:4445–4455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie CH, Cao YM, Huang Y, Shi QW, Guo JH,
Fan ZW, Li JG, Chen BW and Wu BY: Long non-coding RNA TUG1
contributes to tumorigenesis of human osteosarcoma by sponging
miR-9-5p and regulating POU2F1 expression. Tumour Biol.
37:15031–15041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Yang T, Zhang Z, Lu M, Zhao W,
Zeng X and Zhang W: Long non-coding RNA TUG1 promotes migration and
invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells.
Cancer Sci. 108:859–867. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Yu Y, Fan S and Luo L: Knockdown
of long noncoding RNA TUG1 inhibits the proliferation and cellular
invasion of osteosarcoma cells by sponging MiR-153. Oncol Res: Apr
12, 2017 (Epub ahead of print).
|
|
22
|
Cao J, Han X, Qi X, Jin X and Li X: TUG1
promotes osteosarcoma tumorigenesis by upregulating EZH2 expression
via miR-144-3p. Int J Oncol. 51:1115–1123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wada R, Akiyama Y, Hashimoto Y, Fukamachi
H and Yuasa Y: miR-212 is downregulated and suppresses
methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J
Cancer. 127:1106–1114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M,
Quan ZX and Chen J: MicroRNA-212 inhibits osteosarcoma cells
proliferation and invasion by down-regulation of Sox4. Cell Physiol
Biochem. 34:2180–2188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Chen B, Yue B and Yang J:
MicroRNA-212 suppresses the proliferation and migration of
osteosarcoma cells by targeting forkhead box protein A1. Exp Ther
Med. 12:4135–4141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Braicu EI, Gasimli K, Richter R, Nassir M,
Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A,
et al: Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring
response to adjuvant radiochemotherapy in patients with primary
cervical cancer-results of a companion protocol of the randomized
NOGGO-AGO phase III clinical trial. Anticancer Res. 34:385–391.
2014.PubMed/NCBI
|
|
28
|
Ma F, Wang SH, Cai Q, Jin LY, Zhou D, Ding
J and Quan ZW: Long non-coding RNA TUG1 promotes cell proliferation
and metastasis by negatively regulating miR-300 in gallbladder
carcinoma. Biomed Pharmacother. 88:863–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baratieh Z, Khalaj Z, Honardoost MA,
Emadi-Baygi M, Khanahmad H, Salehi M and Nikpour P: Aberrant
expression of PlncRNA-1 and TUG1: Potential biomarkers for gastric
cancer diagnosis and clinically monitoring cancer progression.
Biomark Med. 11:1077–1090. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Y, Leng K, Li Z, Zhang F, Zhong X, Kang
P, Jiang X and Cui Y: The prognostic potential and carcinogenesis
of long non-coding RNA TUG1 in human cholangiocarcinoma.
Oncotarget. 8:65823–65835. 2017.PubMed/NCBI
|
|
31
|
Lei H, Gao Y and Xu X: LncRNA TUG1
influences papillary thyroid cancer cell proliferation, migration
and EMT formation through targeting miR-145. Acta Biochim Biophys
Sin (Shanghai). 49:588–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yun-Bo F, Xiao-Po L, Xiao-Li L, Guo-Long
C, Pei Z and Fa-Ming T: LncRNA TUG1 is upregulated and promotes
cell proliferation in osteosarcoma. Open Med (Wars). 11:163–167.
2016.PubMed/NCBI
|
|
33
|
Liu L, Chen X, Zhang Y, Hu Y, Shen X and
Zhu W: Long non-coding RNA TUG1 promotes endometrial cancer
development via inhibiting miR-299 and miR-34a-5p. Oncotarget.
8:31386–31394. 2017.PubMed/NCBI
|
